Skip to main content
. 2019 Jun 7;5(5):372–377. doi: 10.1016/j.ijwd.2019.05.008

Table 2.

Response rate to rituximab in patients with pemphigus vulgaris in groups A and B

Group A Group B p-value
Response (%) 37 (100) 30 (79.0) .006
Complete remission (%) 22 (59.4) 15 (39.5) .093
Off therapy (%) 3 (8.1) 1 (2.6) .295
Minimal therapy (%) 19 (51.4) 14 (36.8) .211
Partial remission (%) 15 (40.5) 15 (39.4) .923
Off therapy (%) 0 (0) 2 (5.3) .164
Minimal therapy (%) 6 (16.2) 10 (26.3) .293
More than minimal therapy (%) 9 (24.3) 3 (7.9) .060
No response (%) 0 (0) 8 (21.0) .006
Relapse (%) 0 (0) 3 (7.9) .090
Persistent disease activity (%) 0 (0) 5 (13.2) .028